Table 1.

The relationships between MK, ER-β expression in NSCLC and the clinicopathological data.

Characteristic	Cases (n)	MK expression			ER-β expression
Characteristic	Cases (n)	-	+	Positive (%)	-	+	Positive (%)
Sex
Male	19	2	17	89.5	5	14	73.7
Female	5	1	4	80.0	3	2	40.0
Age (years)
< 65	11	2	9	81.8	3	8	72.7
≥ 65	13	1	12	92.3	5	8	61.5
Megascopic type
Central	14	2	12	85.7	4	10	71.4
Peripheral	10	1	9	90.0	4	6	60.0
Tumor size (cm)
< 5	11	1	10	90.9	3	8	72.7
≥ 5	13	2	11	84.6	5	8	61.5
Histological type
Squamous cell carcinoma	7	0	7	100	1	6	85.7
Adenocarcinoma	17	3	14	82.4	7	10	58.8
Pathological classification
I/II	15	0	15	100	2	13	86.7
III	9	3	6	66.7^*	6	3	33.3^*
TNM stage
I/II	19	3	16	84.2	8	11	57.9
III/IV	5	0	5	100	0	5	100
Regional lymph node metastasis
Yes	13	3	10	76.9	4	9	69.2
No	11	0	11	100	4	7	63.6